Skip to Main Content

Paper Details

Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial.
Neurooncol Adv
1
2021
CcO, Cytochrome C oxidase, GBM, GBMs, Glioblastoma, TMZ, glioblastoma, methylated promoter, patients, primary, promoter, temozolomide, tumors
Author NameAffiliation
Christopher S CoffeyUniversity of Iowa
Robin ConwitNational Institutes of Health
Dixie EcklundUniversity of Iowa
Howard ColmanUniversity of Utah
Howard ColmanUniversity of Utah
Milan G ChhedaWashington University School of Medicine
Priya KumthekarFeinberg School of Medicine, Northwestern University
Vinay K PuduvalliOhio State University
  • 1 - 8

Datasets

Release 1.2